Cargando…

Ductal adenocarcinoma of the prostate: immunohistochemical findings and clinical significance

INTRODUCTION: To investigate the clinical features, diagnosis, treatment, and prognosis of ductal adenocarcinoma of the prostate. METHODS: The clinicopathological and immunohistochemical data of seven patients with ductal adenocarcinoma of the prostate were retrospectively analyzed. All patients und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sha, Jianjun, Bo, Juanjie, Pan, Jiahua, Zhang, Lianhua, Xuan, Hanqing, Chen, Wei, Li, Dong, Wang, Zhaoliang, Liu, Dongming, Huang, Yiran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810445/ https://www.ncbi.nlm.nih.gov/pubmed/24187500 http://dx.doi.org/10.2147/OTT.S47165

Ejemplares similares

Incidental Prostate Cancer at the Time of Cystectomy: The Incidence and Clinicopathological Features in Chinese Patients
por: Pan, Jiahua, et al.
Publicado: (2014)

PRKAR2B plays an oncogenic role in the castration-resistant prostate cancer
por: Sha, Jianjun, et al.
Publicado: (2016)

MRI Finding of Prostatic Ductal Adenocarcinoma
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells
por: Zhang, Lianhua, et al.
Publicado: (2018)

An incidentally diagnosed prostatic ductal adenocarcinoma
por: Stajno, Paweł, et al.
Publicado: (2013)

Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma
por: Penheiter, Alan R., et al.
Publicado: (2015)

A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma
por: Herlea, Vlad, et al.
Publicado: (2020)

Immunohistochemical Evaluation of the Expression of Specific Membrane Antigens in Patients with Pancreatic Ductal Adenocarcinoma
por: Nicoletti, Alberto, et al.
Publicado: (2023)

Prognostic Significance of Maspin in Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma
por: Bartholow, Tanner L, et al.
Publicado: (2011)

Multivariate analysis of immunohistochemical evaluation of protein expression in pancreatic ductal adenocarcinoma reveals prognostic significance for persistent Smad4 expression only
por: Ottenhof, Niki A., et al.
Publicado: (2012)

AB140. Efficacy of radical prostatectomy combined with neoadjuvant chemotherapy in the treatment of locally advanced prostate cancer: preliminary experiences from a single center
por: Xue, Wei, et al.
Publicado: (2016)

Pure ductal adenocarcinoma of the prostate protruding into the prostatic urethra: A case report of MRI findings and literature review
por: Yamamoto, Takahiro, et al.
Publicado: (2022)

Ductal Adenocarcinoma of the Prostate: A Case Report
por: Hayashi, Yutaro, et al.
Publicado: (2016)

Genomic analysis of aggressive ductal adenocarcinoma of the prostate
por: Kobayashi, Hiroaki, et al.
Publicado: (2022)

Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
por: Hayashi, Hiromitsu, et al.
Publicado: (2021)

circular RNAs 0000515 and 0011385 as potential biomarkers for disease monitoring and determining prognosis in pancreatic ductal adenocarcinoma
por: Wu, Hanqing, et al.
Publicado: (2022)

The Significance of Tumor Budding and Immunohistochemical Axl Expression in Gallbladder Adenocarcinomas
por: Öz, Özden, et al.
Publicado: (2022)

Clinical necessity of the immunohistochemical reassessment of para-aortic lymph nodes in resected pancreatic ductal adenocarcinoma
por: CHOI, SUNG HOON, et al.
Publicado: (2013)

An Immunohistochemical Evaluation of Tumor-Associated Glycans and Mucins as Targets for Molecular Imaging of Pancreatic Ductal Adenocarcinoma
por: Houvast, Ruben D., et al.
Publicado: (2021)

Galectin-8 Immunohistochemical Profile in Pancreatic Ductal Adenocarcinoma: Emerging Evidence for Its Prognostic Role
por: Rusu, Andreea, et al.
Publicado: (2023)

PRKAR2B‐HIF‐1α loop promotes aerobic glycolysis and tumour growth in prostate cancer
por: Xia, Lei, et al.
Publicado: (2020)

Prognostic Significance of Microvascular Invasion in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis
por: Li, Huangbao, et al.
Publicado: (2021)

Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
por: Linden-Castro, Edgar, et al.
Publicado: (2014)

Case report of prostate ductal adenocarcinoma presenting with hematuria
por: Pawlowski, Jamie, et al.
Publicado: (2018)

Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations
por: Chi, Chenfei, et al.
Publicado: (2022)

MCP-1-Induced Histamine Release from Mast Cells Is Associated with Development of Interstitial Cystitis/Bladder Pain Syndrome in Rat Models
por: Lv, Jianwei, et al.
Publicado: (2012)

Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma
por: Zhang, Hui, et al.
Publicado: (2015)

Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
por: Gebauer, Florian, et al.
Publicado: (2017)

Prognostic Significance of Cofilin Isoforms in Patients With Pancreatic Ductal Adenocarcinoma
por: Islam, Shajedul, et al.
Publicado: (2021)

Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma
por: Matsushita, Katsunori, et al.
Publicado: (2021)

Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma
por: Bartholow, Tanner L, et al.
Publicado: (2011)

Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors
por: Fan, Liancheng, et al.
Publicado: (2018)

Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy
por: Wang, Yanqing, et al.
Publicado: (2016)

FOXF1 as an Immunohistochemical Marker of Hilar Cholangiocarcinoma or Metastatic Pancreatic Ductal Adenocarcinoma. Single Institution Experience
por: Hrudka, Jan, et al.
Publicado: (2021)

Immunohistochemical categorisation of ductal carcinoma in situ of the breast
por: Meijnen, P, et al.
Publicado: (2008)

Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance
por: Zou, Xuan, et al.
Publicado: (2023)

Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal Adenocarcinoma
por: Jiang, Zhengting, et al.
Publicado: (2022)

Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate
por: Schweizer, Michael T., et al.
Publicado: (2016)

Diverse Immunoprofile of Ductal Adenocarcinoma of the Prostate with an Emphasis on the Prognostic Factors
por: Jeong, Se Un, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_egpm3u3ddgrmcf03oq21m9hm9u